The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, ...

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection ...

The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile ...

The Department of Health and Human Services has long advocated vaccination as a key component of public health. Before Robert F. Kennedy, Jr. was confirmed as secretary of the nation’s top ...

The next wave of metabolic medicines in development includes oral GLP-1 drugs that work comparably to currently available injectable medicines, and Eli Lilly is taking the lead with Phase 3 ...

The digital health funding market has been way up and way down over the past five years. As this roller coaster starts to settle down, one thing is clear to Randy Bolyga: that the industry is ...

The scent of eucalyptus oil wafts through more households than ever. Herbal teas promising immunity boosts line mainstream grocery store shelves. Social media teems with influencers touting the ...

With rising operational costs, major shifts in Medicaid, and other financial pressures bearing down on the healthcare system, forecasting revenue and allocating resources effectively has never ...

The journey of rare disease patients and their families can be a long one marked by misdiagnoses, and so it is for those who have the ultra-rare disorder with the abbreviated name PMM2-CDG.